![Sang-Woo Park](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sang-Woo Park
Algemeen Directeur bij NKMAX CO., LTD.
Vermogen: 671 775 $ op 31-05-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Yong Man Kim | M | 58 |
NKGen Biotech, Inc.
![]() NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA.
NKMAX Co., Ltd.
![]() NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea. | 7 jaar |
Pierre Gagnon | M | 51 |
NKGen Biotech, Inc.
![]() NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA.
NKMAX Co., Ltd.
![]() NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea.
ATGen Canada, Inc.
| 15 jaar |
Paul Y. Song | M | 58 | 6 jaar | |
James Graf | M | 59 | - | |
Yong-Hwan Cho | M | 52 |
Atgen H&D
![]() Atgen H&D Pharmaceuticals: OtherHealth Technology Atgen H&D develops protein products. Sang-Woo Park has been the CEO of the South Korean company since 2016. | 9 jaar |
Michael Klowden | M | 79 | 1 jaar | |
Kathleen Scott | F | 55 | 1 jaar | |
Kang-Yong Pierre | M | 52 | 15 jaar | |
Jeong-Heon Cha | M | 58 | - | |
Ryan Park | M | - | 5 jaar | |
Yong-Man Kim | M | 58 | 5 jaar | |
Jun-Yong Song | M | 57 | - | |
Jeong-Chan Lee | M | 67 | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Woo-Sik Choi | M | 55 | - | |
Alana McNulty | F | 61 | 1 jaar | |
Jae-Ho Cheong | M | 54 | - | |
Jong-Sun Kim | M | 61 | 3 jaar | |
Jae-Myeon Lee | M | 57 | - | |
Chung-Kyo Park | M | 63 | 3 jaar | |
Ho-Geun Yoon | M | 54 | - | |
Kyung-Mo Gu | M | 43 | 1 jaar | |
Seung-Ju Ham | M | 59 | - | |
Jong-Yoon Lee | M | 56 | 3 jaar | |
Chang-Wook Jang | M | 50 | - | |
Ki-Jong Hong | M | 59 | - |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Zuid-Korea | 20 | 80.00% |
Verenigde Staten | 2 | 8.00% |
Canada | 1 | 4.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Sang-Woo Park
- Persoonlijk netwerk